Stimulation of sodium chloride absorption from secreting rat colon by short-chain fatty acids.
Inhibition of electroneutral NaCl absorption by cyclic adenosine monophosphate (cAMP) results in fluid malabsorption in cholera. Short-chain fatty acids (SCFA) stimulate electroneutral NaCl absorption from the colon. The present study investigated effects of elevated cAMP on SCFA-stimulated NaCl absorption in rat distal colon. The effect of SCFA on fluxes of 22Na and 36Cl was studied under voltage-clamp conditions, in the presence and absence of secretagogues inducing mucosal cAMP elevation [ie, theophylline, cholera toxin (CT) and forskolin]. The effect of butyrate concentration on Na absorption in CT- and theophylline-treated mucosa was compared with control normal mucosa. cAMP was measured in isolated colonocytes in the presence of secretagogues with and without SCFA using a radioassay method. All secretagogues were noted to inhibit net Na absorption and to induce net Cl secretion. In the presence of SCFA, net Na absorption was normal, and net Cl secretion was partly reversed. The flux data indicated that NaCl absorption from secreting colon was stimulated by SCFA and that Cl secretion was partially inhibited. The effects of SCFA on NaCl absorption were similar regardless of the secretagogue used. The kinetics of butyrate-stimulated Na absorption were altered by theophylline and CT, which decreased Km (6.87 and 7.17, respectively, compared to 10.75 mM for control) and increased Vmax (4.55 and 8.33 compared to 3.45 mM/eq/cm2/hr for control). cAMP production by colonocytes in response to secretory stimuli was significantly reduced (34.4%) by butyrate but not by acetate or propionate. In conclusion, SCFA-stimulated Na absorption is up-regulated by cAMP and may be an absorptive pathway that can be utilized in the therapy of cholera. Effects of butyrate on cAMP generation are also likely to be useful in secretory diarrhea.
Krishnan
S
S
Department of Gastrointestinal Sciences, Christian Medical College Hospital, Vellore, India.
Ramakrishna
B S
BS
Binder
H J
HJ
D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002772:Cholera Toxin / Q000494:pharmacology; D005576:Colforsin / Q000494:pharmacology; D003106:Colon / Q000378:metabolism*; D000242:Cyclic AMP / Q000096:biosynthesis; D005232:Fatty Acids, Volatile / Q000494:pharmacology*; D007408:Intestinal Absorption / Q000187:drug effects*; D007700:Kinetics; D051381:Rats; D017208:Rats, Wistar; D012965:Sodium Chloride / Q000493:pharmacokinetics*; D013806:Theophylline / Q000494:pharmacology
D005232:Fatty Acids, Volatile; D005576:Colforsin; D012965:Sodium Chloride; D002772:Cholera Toxin; D013806:Theophylline; D000242:Cyclic AMP